Identifying bladder problems and the risk factors in children with cancer undergoing chemotherapy - A Prospective Study
Not Applicable
- Conditions
- Health Condition 1: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue
- Registration Number
- CTRI/2024/04/066088
- Lead Sponsor
- Swathi PM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Survivors of childhood cancer
2.Age = 5 years
3.Parents/guardians providing informed consent.
Exclusion Criteria
1.Survivors with congenital Genito urinary malformations, Genetic syndromes, spinal defects, and neurologic disorder
2.Parents who refuse to consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association between chemotherapeutic agents and their cumulative dose with development of LUTDSTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method assessing the risk factors for LUTD in cancer survivor children on chemotherapyTimepoint: 6 months